Hirudoid Forte

Hirudoid Forte is a topical preparation that contains the active ingredient chondroitin polysulfate. It is marketed in the European Union and is classified as a heparinoid with antithrombotic and anti‑inflammatory properties. The product is applied to the skin to address localized bruising, hematoma, superficial thrombophlebitis, and other inflammatory skin conditions, offering a non‑systemic therapeutic option.

Hirudoid Forte is indicated for several superficial vascular and inflammatory skin conditions where localized treatment is preferred.

- Management of bruising (ecchymosis) resulting from trauma or surgery. - Treatment of hematoma to reduce swelling and promote resolution. - Supportive care for superficial thrombophlebitis to improve venous flow. - Relief of mild inflammatory skin conditions such as localized edema. - Adjunct therapy for post‑procedural skin discoloration.

Adverse reactions to Hirudoid Forte are generally mild and limited to the application site.

Common: - Mild skin irritation or erythema at the site of application. - Pruritus or itching. - Transient burning sensation. - Dryness or peeling of the treated skin.

Serious: - Allergic contact dermatitis with vesiculation. - Severe localized edema or urticaria. - Development of necrotic skin lesions (rare). - Systemic hypersensitivity reactions such as angioedema.

When using Hirudoid Forte, consider the following safety measures to minimize risks.

- Avoid application on broken, infected, or ulcerated skin. - Do not use on large surface areas or under occlusive dressings unless directed by a healthcare professional. - Discontinue use if signs of allergic reaction appear and seek medical advice. - Pregnant or breastfeeding individuals should consult a physician before use. - Keep out of reach of children; accidental ingestion requires immediate medical attention. - Store at room temperature, protected from excessive heat and moisture.

Topical chondroitin polysulfate may interact with other agents applied to the same skin area.

Avoid: - Concurrent use with other topical anticoagulants (e.g., heparin creams) without medical supervision. - Application over areas treated with potent corticosteroids or non‑steroidal anti‑inflammatory gels.

Use with caution: - Combining with systemic anticoagulant therapy (e.g., warfarin) if extensive skin coverage is planned. - Use alongside other heparinoid‑containing products in adjacent regions. - Application in patients using topical antibiotics, as irritation may increase absorption. - Use in individuals with known hypersensitivity to chondroitin derivatives.